Methotrexate and Coreg cr drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methotrexate (methotrexate sodium) and Coreg cr (carvedilol phosphate). Common drug interactions include atrioventricular block among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Methotrexate and Coreg cr. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Methotrexate?

Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 604,313 Methotrexate users. Check the latest studies of Methotrexate.

What is Coreg cr?

Coreg cr has active ingredients of carvedilol phosphate. It is often used in high blood pressure. eHealthMe is studying from 1,628 Coreg cr users. Check the latest studies of Coreg cr.



On Aug, 07, 2026

18 people who take Methotrexate and Coreg cr together, and have interactions are studied.

Methotrexate and Coreg cr drug interactions.

What are the common drug interactions of Methotrexate and Coreg Cr, by gender? *:

female:

  1. Atrioventricular block (heart block)
  2. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  3. Injection site pain
  4. Joint range of motion decreased (disease of joint movement)
  5. Localised infection (infection at the single location)
  6. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  7. Tendonitis (a condition that causes pain and swelling of tendons)
  8. Blood pressure fluctuation
  9. Cardiac pacemaker replacement
  10. Cardiovascular disorder (heart diseases)

male:

  1. Fall
  2. Pruritus (severe itching of the skin)
  3. Abscess (pus)
  4. Cellulitis staphylococcal (a type of bacteria originated skin soft tissue infection)
  5. Hip fracture
  6. Rash erythematous (redness of the skin)
  7. Ulcer haemorrhage (bleeding ulcer)
  8. Vertigo

What are the common drug interactions of Methotrexate and Coreg Cr, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Vertigo

30-39:

n/a

40-49:

  1. Blood glucose increased
  2. Chest discomfort
  3. Chills (felling of cold)
  4. Dizziness
  5. Drug hypersensitivity
  6. Erythema (redness of the skin)
  7. Feeling hot
  8. Gallbladder pain
  9. Headache (pain in head)
  10. Heart rate increased

50-59:

  1. Cellulitis (infection under the skin)
  2. Phlebitis (inflammation of the walls of a vein)
  3. Thrombosis (formation of a blood clot inside a blood vessel)

60+:

  1. Arthralgia (joint pain)
  2. Joint range of motion decreased (disease of joint movement)
  3. Hip fracture
  4. Hyperhidrosis (abnormally increased sweating)
  5. Injection site pain
  6. Local swelling (swelling at the site of some application of substance or injury)
  7. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  8. Oral mucosal blistering (mouth ulcer)
  9. Rash erythematous (redness of the skin)
  10. Visual impairment

What are the existing conditions these people have? *

  1. Cardiac Disorder: 3 people, 16.67%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.11%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 11.11%
  4. Cardiac Failure Congestive: 2 people, 11.11%
  5. High Blood Cholesterol: 2 people, 11.11%
  6. Gastric Disorder (disease of stomach): 2 people, 11.11%
  7. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 5.56%
  8. Asthma: 1 person, 5.56%
  9. B-Cell Lymphoma Stage Iv (blood cancer affecting b cells stage iv): 1 person, 5.56%
  10. Cardiomyopathy (weakening of the heart muscle): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Methotrexate and Coreg cr?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Methotrexate and Coreg cr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methotrexate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Coreg cr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methotrexate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Coreg cr and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on methotrexate sodium and carvedilol phosphate (the active ingredients of Methotrexate and Coreg cr, respectively), and Methotrexate and Coreg cr (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: